health services

industry closed the day down 4.5%.

Pressure BioSciences Inc




Psychemedics Corporation




Escalon Medical Corporation



), and

Heartware International Inc



) were all winners today within the health services industry with

Pharmaceutical Product Development Inc



) being today's featured health services winner. Pharmaceutical Product Development Inc rose $6.64 (25.9%) to $32.30 on heavy volume. Throughout the day, 33.4 million shares of Pharmaceutical Product Development Inc exchanged hands as compared to its average daily volume of 1.5 million shares.

Pharmaceutical Product Development, Inc., a contract research organization, provides drug discovery, development, and lifecycle management services. It operates in two segments, Development and Laboratory Services. Pharmaceutical Product Development Inc has a market cap of $3 billion and is part of the

health care

sector. The company has a P/E ratio of 41.6, above the average health services industry P/E ratio of 18.2 and above the S&P 500 P/E ratio of 17.7. Shares are down 5.5% year to date as of the close of trading on Friday.

TheStreet Ratings rates Pharmaceutical Product Development as a


. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, revenue growth, reasonable valuation levels and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the negative front,

Gentiva Health Services Inc




World Heart Corporation




Fonar Corporation



), and

Sun Healthcare Group Inc



) were all losers within the health services industry with

Boston Scientific Inc



) being today's health services industry Loser Spotlight stock.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR



) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care